Lumida
/ONT
⌘K
ONT

ONT

ONT
$18.33USD+0.94%+0.17 today

MARKET CAP

643.7M

P/E (TTM)

FWD P/E

DAY RANGE

$18 – $19

52W RANGE

$0
$23

AI Summary

Stalk
Buy NowMedium

ONT is in a Stage 2 advancing regime with a bullish Higher Highs & Higher Lows pattern signaling demand dominance and asymmetric upside. Price is tightly tracking above rising 9- and 20-day EMAs without exhaustion, favoring continuation participation. We recommend buying now for shallow pullbacks or breakouts near the EMA band. Key risks include overbought RSI, potential momentum fatigue, and overhead 50-day SMA resistance.

  • Real-time DNA sequencing adoption rising in healthcare and research.
  • Strong liquidity underpins operations and funds growth initiatives.
  • Negative profitability track record limits sustainable returns.
Full analysis →

Buying

6

institutions

Selling

3

institutions

New Positions

2

this quarter

Filing Period

Q1 2026

latest 13-F

13-F Holdings

InstitutionActionShares HeldValueChangeChg %Weight
BI

Blackrock, Inc.

Q2 2026

BUY3.27 M66.19 M+124.13 K-4.0%0.00%
JH

Janus Henderson Group Plc

Q1 2026

BUYNEW1.73 M37.96 M+1.73 M+0.0%0.01%
MM

Millennium Management LLC

Q2 2026

BUY441.15 K8.92 M+129.99 K+30.9%0.00%
FA

Fisher Asset Management, LLC

Q2 2026

BUYNEW332.02 K6.71 M+332.02 K+0.0%0.00%
CA

Citadel Advisors LLC

Q2 2026

SELL214.78 K4.34 M+-54.00 K-26.2%0.00%
RC

Rockefeller Capital Management L.P.

Q2 2026

BUY131.01 K2.65 M+2.82 K-5.6%0.00%
AC

Aqr Capital Management LLC

Q2 2026

SELL29.64 K599.07 K+-81.43 K-75.4%0.00%
JC

Jpmorgan Chase & Co

Q2 2026

BUY16.88 K344.42 K+145.00-2.0%0.00%
MG

Man Group Plc

Q2 2026

SELL0.000.00+-34.80 K-100.0%0.00%